# Spravex

NDC: 85477-327
Generic name: Spravex
Labeler / Manufacturer: Oncora Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Unapproved drug (not FDA-reviewed)
Dosage form: SPRAY
Routes: TOPICAL
Marketing started: 20261020



## Active ingredients

- LIDOCAINE: 41.2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"85477-327"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=85477-327